STAG3L4
Putative STAG3-like protein 4
Also known as: ST3L4_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for STAG3L4 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
150 residues, UniProt reviewed canonical sequence.
>Q8TBR4|STAG3L4
1 MSGWIATSKT RMQDFWSLLT FSSDLVDVKD SGDYPLTAPG LSWKKFQGSF CEFVGTLVCR
61 CQYILLHDDF PMDNLISLLT GFSDSQVCAF CHTSTLAAMK LMTSLVRVAL QLSLHEDINQ
121 RQYEAERNKG PGQRAPERLE SLLEKHKELHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STAG3L4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STAG3L4 as an antibody target. Whether an autoantibody or antibody against STAG3L4 could matter depends on whether native STAG3L4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STAG3L4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STAG3L4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...